FDA Hypocritically Approves New Synthetic Cannabis
The U.S. Food and Drug Administration (FDA) has approved a new synthetic marijuana. The liquid formulation of dronabinol — a synthetic form of the psychoactive compound in cannabis: tetrahydrocannabinol (THC), was officially approved a few weeks ago. Allegedly, the synthetic cannabis will be sold under the name of Syndros and is classified Schedule III substance under the Controlled Substances Act. Dronabinol has been sold since the mid-1980s under the name, Marinol. The difference between Syndros and Marinol is that Syndros is [...]
